Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-002304-40Phase 4Completed
Phase 4, randomised, double-blind trial in postoperative pain comparing TQL block with Naropin (ropivacaine) with TQL block with normal saline placebo (2 arms). Primary endpoint: cumulative 24-hour morphine consumption. Started Aug 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-002304-40.